First Republic Investment Management, Inc. Bausch Health Companies Inc. Transaction History

First Republic Investment Management, Inc.

$34.7 Billion
Q3 2023

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 30, 2019	SELL	$20.23 - $26.29 $356,088 - $462,756	-17,602 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$17.64 - $28.32 $6.77 Million - $10.9 Million	-383,739 Reduced 95.61%	17,602 $325,000
Q3 2018 Nov 13, 2018	BUY	$20.64 - $25.67 $8.28 Million - $10.3 Million	401,341 New	401,341 $10.3 Million

Others Institutions Holding BHC

# of Institutions

270

Shares Held

252M

Call Options Held

5.12M

Put Options Held

9.43M

Icahn Carl C Sunny Isles Beach, FL

34.7M
Shares

$249 Million
3.8% of portfolio
Goldentree Asset Management LP New York, NY

27.5M
Shares

$197 Million
16.77% of portfolio
John Paulson Paulson & Co. Inc. | New York, Ny

26.4M
Shares

$190 Million
12.9% of portfolio
National Bank Of Canada

15.4M
Shares

$111 Million
0.17% of portfolio
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A6

13M
Shares

$93.2 Million
0.23% of portfolio

View Full List

About Bausch Health Companies Inc.

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.59B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

More about BHC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Account